ES Pharma SRL
ES Pharma reported total assets of 84,690 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jun 2026).
The score of ES Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ES Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
ES Pharma's financial analysis
- Solvency55.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ES Pharma
ES Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1009.079.320
- VAT number
- BE1009079320
- Peppol
- Registered · 0208:1009079320 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 May 2024
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 03 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ES Pharma (SRL) has been based in Mol since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 32,777 € and equity of 46,820 €; its revenue is not published. Its solvency stands at 55.3%, above the median of its sector (44.2%).
Companies similar to ES Pharma
Companies in the same business, of comparable size and area, outside its group.
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
- Smilla Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet 70,168 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- FarmaST Retail sale of pharmaceutical products Zonhoven · balance sheet 107,177 €
- Bartholomees Evaline Retail sale of pharmaceutical products Pelt · balance sheet 120,179 €
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
- L.V. Farma Retail sale of pharmaceutical products Hasselt · balance sheet 83,799 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
Frequently asked questions about ES Pharma
What is the revenue of ES Pharma?
ES Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ES Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1009079320 for ES Pharma, if the company is VAT-registered. Its company number (CBE) is 1009.079.320.
Where is the registered office of ES Pharma?
According to the CBE register, the registered office of ES Pharma is in 2400 Mol.
What is the equity of ES Pharma?
At the close of the 2025 financial year, the equity of ES Pharma amounts to 46,820 €, a solvency of 55.3% of total assets.
Who manages ES Pharma?
The register lists 1 active mandates at ES Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ES Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →